Purpose: The study aimed at measuring the amount of the gadobenate ion
that crosses an experimentally disrupted blood-brain barrier (BBB) in
rats following i.v. administration of gadobenate dimeglumine (GD). Th
e intention was also to compare this amount with the minimally effecti
ve intrathecal dose that alters the cerebral function. Methods: Spragu
e Dawley rats with an osmotically disrupted BBB received 0.3 mmol/kg o
f (Gd-153)GD, i.v. Radioactivity was measured in plasma and brain pare
nchyma. The effect on the cerebral function was evaluated by means of
a standard motor coordination test (Rota-rod test). Results: Brain lev
els of the gadobenate ion were approximately 60 nmol/g tissue after i.
v. injection of GD. In rats with an intact BBB, the lowest dose of GD
able to slightly impair motor coordination was 0.01 mmol/kg following
intracisternal injection. Conclusion: I.v. administration of GD to rat
s with a disrupted BBB results in brain levels of the gadobenate ion t
hat are more than 20 times lower than those reached following intrathe
cal administration of the minimal effective dose, as determined by the
Rota-rod test.